Effects of Panax Ginseng and Salvia Miltiorrhiza Supplementation on Vascular Function
1 other identifier
interventional
48
1 country
1
Brief Summary
The purpose of is to determine the preventive effects of Chinese herb supplement with panax ginseng and salvia miltiorrhiza prior to eccentric resistance exercise on arterial stiffness and vascular reactivity by using a double-blind randomized control design and to examine the effects of a 12-week progressive eccentric resistance exercise training on arterial elasticity and vascular reactivity, and whether a long-term supplementation would ameliorate arterial stiffening effects elicited by exercise-induced inflammation and improve endothelial function.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2012
CompletedFirst Submitted
Initial submission to the registry
December 4, 2013
CompletedFirst Posted
Study publicly available on registry
December 10, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2014
CompletedDecember 10, 2013
December 1, 2013
1.7 years
December 4, 2013
December 5, 2013
Conditions
Outcome Measures
Primary Outcomes (3)
Pulse Wave Velocity
PWV will be measured before, 6th week, 12th week of eccentric exercise training.
Before eccentric exercise and training
Pulse Wave Velocity
PWV will be measured before, 6th week, 12th week of eccentric exercise training.
6th week of eccentric exercise traininig
Pulse Wave Velocity
PWV will be measured before, 6th week, 12th week of eccentric exercise training.
12th week of eccentric exercise training
Secondary Outcomes (3)
Blood pressure
Before intervention
Blood pressure
6th week of intervention
Blood pressure
12th week of intervention
Study Arms (2)
Herbs
EXPERIMENTALparticipants assigned to experimental arm will take 300mg panax ginseng and 300mg salvia miltiorrhiza extracts in capsules for 12 weeks along with eccentric exercise training
Placebo
PLACEBO COMPARATORparcipants in this group will take placebo capsule containing microcrystalline cellulose
Interventions
Eligibility Criteria
You may qualify if:
- Healthy sedentary adults
You may not qualify if:
- obesity (BMI \>30 kg/m2)
- smoking within past six months
- hypertension (high blood pressure \>140/90 mmHg)
- personal history of diabetes (fasting blood glucose \>126 mg/dL), heart disease, or other cardiovascular problems
- orthopedic injury that may prevent him or her from completing the exercise
- the use of over-the-counter supplements or vitamins
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University
Taipei, 106, Taiwan
Related Publications (2)
Lin HF, Chou CC, Chao HH, Tanaka H. Panax ginseng and Salvia miltiorrhiza supplementation during eccentric resistance training in middle-aged and older adults: A double-blind randomized control trial. Complement Ther Med. 2016 Dec;29:158-163. doi: 10.1016/j.ctim.2016.10.003. Epub 2016 Oct 11.
PMID: 27912940DERIVEDLin HF, Tung K, Chou CC, Lin CC, Lin JG, Tanaka H. Panax ginseng and salvia miltiorrhiza supplementation abolishes eccentric exercise-induced vascular stiffening: a double-blind randomized control trial. BMC Complement Altern Med. 2016 Jun 6;16:168. doi: 10.1186/s12906-016-1139-4.
PMID: 27266702DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Hsin-Fu Lin, Ph.D
National Taiwan University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 4, 2013
First Posted
December 10, 2013
Study Start
November 1, 2012
Primary Completion
July 1, 2014
Last Updated
December 10, 2013
Record last verified: 2013-12